Of note, HuR liver-specific deletion (HuRhKO) was also found to promote the transition from simple steatosis to NASH in mice fed with a high-fat diet through the activation of the fibrosis/HSC pathway and the inhibition of the farnesoid X receptor (FXR) pathway [28]. This evidence concerns the gene ELAVL1 and metabolic dysfunction-associated steatohepatitis.